Immune ablation and stem-cell therapy in autoimmune disease: Immunological reconstitution after high-dose immunosuppression and haematopoietic stem-cell transplantation

Por van Laar, Jacob M
Publicado em 2000

B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis

Por van Laar, Jacob M
Publicado em 2010

Stem Cell Therapy: Resetting Autoimmunity or Postponing the Inevitable?

Por van Laar, Jacob M.
Publicado em 2011

Stem cell transplantation for rheumatic autoimmune diseases

Por Hügle, Thomas, van Laar, Jacob M
Publicado em 2008

Allogeneic stem cell transplantation for rheumatic autoimmune diseases

Por Hügle, Thomas, van Laar, Jacob M
Publicado em 2010

The immunopathology of systemic sclerosis

Por van Laar, Jacob M., Varga, John
Publicado no Semin Immunopathol (2015)

The role of B cells in systemic sclerosis

Por Kraaij, Marina D, van Laar, Jacob M
Publicado em 2008

Tweaking Microtubules to Treat Scleroderma

Por van Laar, Jacob M, Huizinga, Tom W. J
Publicado em 2005

Cell therapy for autoimmune diseases

Por Dazzi, Francesco, van Laar, Jacob M, Cope, Andrew, Tyndall, Alan
Publicado em 2007

Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-β (TGF-β) Signaling Promoting SMAD3 Activation and Fibros...

Por O'Reilly, Steven, Ciechomska, Marzena, Cant, Rachel, van Laar, Jacob M.
Publicado em 2014

Interleukin-6: a new therapeutic target in systemic sclerosis?

Por O'Reilly, Steven, Cant, Rachel, Ciechomska, Marzena, van Laar, Jacob M
Publicado no Clin Transl Immunology (2013)

Applied machine learning and artificial intelligence in rheumatology

Por Hügle, Maria, Omoumi, Patrick, van Laar, Jacob M, Boedecker, Joschka, Hügle, Thomas
Publicado no Rheumatol Adv Pract (2020)

Differentiation Potential of CD14(+) Monocytes into Myofibroblasts in Patients with Systemic Sclerosis

Por Binai, Nadine, O'Reilly, Steven, Griffiths, Bridget, van Laar, Jacob M., Hügle, Thomas
Publicado em 2012

IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics

Por O’Reilly, Steven, Ciechomska, Marzena, Fullard, Nicola, Przyborski, Stefan, van Laar, Jacob M.
Publicado no Sci Rep (2016)

Corrigendum: IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics

Por O’Reilly, Steven, Ciechomska, Marzena, Fullard, Nicola, Przyborski, Stefan, van Laar, Jacob M.
Publicado no Sci Rep (2016)

Autologous hematopoietic stem cell transplantation for autoimmune disease – is it now ready for prime time?

Por Atkins, Harold L., Muraro, Paolo A., van Laar, Jacob M., Pavletic, Steven Z.
Publicado no Biol Blood Marrow Transplant (2012)

The clinical utility of bone marker measurements in osteoporosis

Por Wheater, Gillian, Elshahaly, Mohsen, Tuck, Stephen P, Datta, Harish K, van Laar, Jacob M
Publicado em 2013

MiR-29a Reduces TIMP-1 Production by Dermal Fibroblasts via Targeting TGF-β Activated Kinase 1 Binding Protein 1, Implications for Systemic Sclerosis

Por Ciechomska, Marzena, O’Reilly, Steven, Suwara, Monika, Bogunia-Kubik, Katarzyna, van Laar, Jacob M.
Publicado no PLoS One (2014)

Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study

Por Wheater, Gillian, Elshahaly, Mohsen, Naraghi, Kamran, Tuck, Stephen P., Datta, Harish K., van Laar, Jacob M.
Publicado no PLoS One (2018)

Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-κB

Por O'Reilly, Steven, Cant, Rachel, Ciechomska, Marzena, Finnigan, James, Oakley, Fiona, Hambleton, Sophie, van Laar, Jacob M
Publicado em 2014